Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395863 · ClinicalTrials.gov registry record · Phase 4
Multihance at 3 Tesla (3T) in Brain Tumors
A Phase 4 study, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT00395863 is a Phase 4 study that has completed, run by Bracco Diagnostics. The registered enrollment target is 46 participants.
The verdict
NCT00395863, a Phase 4 study, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
Compare the efficacy of MultiHance and Magnevist
Interventions
- DRUG Multihance
- DRUG Arm 2 - Magnevist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395863
The ClinicalTrials.gov registry entry for NCT00395863 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Multihance is the first listed.
NCT00395863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395863 about?
NCT00395863 is a clinical study titled "Multihance at 3 Tesla (3T) in Brain Tumors". Compare the efficacy of MultiHance and Magnevist
What is the current status of trial NCT00395863?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2006-11. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00395863?
The interventions under investigation include: Multihance (DRUG), Arm 2 - Magnevist (DRUG).
Who is sponsoring clinical trial NCT00395863?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.